Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	88075702	FILING DATE	08/13/2018
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	REINHART, MEGHAN M	L.O. ASSIGNED	108

PUB INFORMATION
RUN DATE	04/02/2021
PUB DATE	08/06/2019
STATUS	732-THIRD EXTENSION - GRANTED
STATUS DATE	03/31/2021
LITERAL MARK ELEMENT	AIONCO
DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	NO
LITERAL MARK ELEMENT	AIONCO
MARK DRAWING CODE	3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG	YES

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Gene Lee
ADDRESS	Unit 421 151 El Camino Real San Jose, CA 94030
ENTITY	01-INDIVIDUAL
CITIZENSHIP	United States of America

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Medical testing products, namely, modified immune cells; Medical testing products, namely, modified immune cells for use in connection with various cancers with genetic treatments
INTERNATIONAL CLASS	009
DESCRIPTION TEXT	Downloadable software and mobile applications for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating local databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, and for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping; medical testing products, namely, downloadable vaccination test forms
INTERNATIONAL CLASS	010
DESCRIPTION TEXT	Medical testing and treatment products in the form of treatment therapies, namely, apparatus for medical diagnosis, drug delivery apparatus and genetic delivery apparatus all for various cancers with genetic treatments and specimen collection tubes and containers for collecting patient specimens, namely, blood, urine, saliva, and tissue, for genomic sequencing and for detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer; Medical testing and treatment product kits containing blood specimen collection tubes and containers for collecting patient blood specimens for genomic sequencing and detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer modified immune cells and treatment therapies, and also containing modified immune cells, treatment therapies, test forms, mailing materials and user information inserts
INTERNATIONAL CLASS	016
DESCRIPTION TEXT	Medical testing and treatment products, namely, printed test forms and printed user information inserts for medical products; Medical testing products, namely, printed vaccination test forms
INTERNATIONAL CLASS	042
DESCRIPTION TEXT	Providing online non-downloadable software and software programs for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, and for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
INTERNATIONAL CLASS	044
DESCRIPTION TEXT	Providing medical diagnostic and treatment services, namely, tumor detection in the form of a liquid biopsy; medical diagnostic and treatment services in the nature of tumor analysis, diagnosis, and identification in the form of sequenced tissue identification, and tumor medical treatment therapy in the form of identification of appropriate combination of mutations for targeted cancers and identification of appropriate treatments targeted for those combination of mutations via modified T-Cells in the form of other treatments to inhibit expressions of those combination of mutations and to modify one or more of the mutations in the combination

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE
INTERNATIONAL CLASS	009	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE
INTERNATIONAL CLASS	010	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE
INTERNATIONAL CLASS	016	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE
INTERNATIONAL CLASS	042	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE
INTERNATIONAL CLASS	044	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO
COLORS CLAIMED STATEMENT	The color(s) blue, teal, orange, and red is/are claimed as a feature of the mark.
DESCRIPTION OF MARK	The mark consists of a circle which is circumscribed appearing next to the word "AIONCO" in a stylized font resembling a DNA sequence in orange and red color. Within the ring of the circle are other circles layered together with colors blue and teal. The background is transparent. White is not claimed as a color of the mark.

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
04/02/2021	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	046
03/31/2021	EX3G	S	EXTENSION 3 GRANTED	045
03/31/2021	EXT3	S	EXTENSION 3 FILED	044
03/31/2021	EEXT	I	TEAS EXTENSION RECEIVED	043
10/02/2020	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	042
09/30/2020	EX2G	S	EXTENSION 2 GRANTED	041
09/30/2020	EXT2	S	EXTENSION 2 FILED	040
09/30/2020	EEXT	I	TEAS EXTENSION RECEIVED	039
04/03/2020	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	038
04/02/2020	EX1G	S	EXTENSION 1 GRANTED	037
03/31/2020	EXT1	S	EXTENSION 1 FILED	036
04/02/2020	CHAN	I	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	035
04/02/2020	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	034
03/31/2020	EEXT	I	TEAS EXTENSION RECEIVED	033
03/31/2020	CHAN	I	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	032
03/31/2020	TCCA	I	TEAS CHANGE OF CORRESPONDENCE RECEIVED	031
03/31/2020	ARAA	I	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	030
03/31/2020	REAP	I	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	029
03/31/2020	COAR	I	TEAS CHANGE OF OWNER ADDRESS RECEIVED	028
10/01/2019	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	027
08/06/2019	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	026
08/06/2019	PUBO	A	PUBLISHED FOR OPPOSITION	025
07/17/2019	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	024
07/03/2019	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	023
07/03/2019	XAEC	I	EXAMINER'S AMENDMENT ENTERED	022
07/03/2019	GNEN	O	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	021
07/03/2019	GNEA	O	EXAMINERS AMENDMENT E-MAILED	020
07/03/2019	CNEA	R	EXAMINERS AMENDMENT -WRITTEN	019
07/01/2019	ZZZX	Z	PREVIOUS ALLOWANCE COUNT WITHDRAWN	018
06/18/2019	PBCR	Z	WITHDRAWN FROM PUB - OG REVIEW QUERY	017
05/30/2019	ALIE	A	ASSIGNED TO LIE	016
05/16/2019	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	015
05/16/2019	XAEC	I	EXAMINER'S AMENDMENT ENTERED	014
05/16/2019	GNEN	O	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	013
05/16/2019	GNEA	O	EXAMINERS AMENDMENT E-MAILED	012
05/16/2019	CNEA	R	EXAMINERS AMENDMENT -WRITTEN	011
04/30/2019	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	010
04/29/2019	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	009
04/29/2019	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	008
11/26/2018	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	007
11/26/2018	GNRT	F	NON-FINAL ACTION E-MAILED	006
11/26/2018	CNRT	R	NON-FINAL ACTION WRITTEN	005
11/15/2018	DOCK	D	ASSIGNED TO EXAMINER	004
08/22/2018	MDSC	E	NOTICE OF DESIGN SEARCH CODE E-MAILED	003
08/21/2018	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
08/16/2018	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Andrew J. Gray IV
CORRESPONDENCE ADDRESS	Andrew J. Gray IV Morgan, Lewis & Bockius LLP 1400 Page Mill Road Palo Alto CA 94304
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Gene Lee
ADDRESS	Unit 421 151 El Camino Real San Jose, CA 94030
ENTITY	01-INDIVIDUAL
CITIZENSHIP	United States of America